These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23910702)

  • 1. Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure.
    Basoor A; Doshi NC; Cotant JF; Saleh T; Todorov M; Choksi N; Patel KC; Degregorio M; Mehta RH; Halabi AR
    Congest Heart Fail; 2013; 19(4):200-6. PubMed ID: 23910702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
    Matthews JC; Johnson ML; Koelling TM
    Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving quality of care in patients with decompensated acute heart failure using a discharge checklist.
    Legallois D; Chaufourier L; Blanchart K; Parienti JJ; Belin A; Milliez P; Sabatier R
    Arch Cardiovasc Dis; 2019; 112(8-9):494-501. PubMed ID: 31353278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: are effects maintained after stopping the programme?
    Ojeda S; Anguita M; Delgado M; Atienza F; Rus C; Granados AL; Ridocci F; Vallés F; Velasco JA
    Eur J Heart Fail; 2005 Aug; 7(5):921-6. PubMed ID: 16051519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
    Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
    Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a clinical-decision-support system in improving compliance with cardiac-care quality measures and supporting resident training.
    Riggio JM; Sorokin R; Moxey ED; Mather P; Gould S; Kane GC
    Acad Med; 2009 Dec; 84(12):1719-26. PubMed ID: 19940579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
    Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
    Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of post PCI medical checklist to improve adhering with best practice guidelines in the patients with coronary artery disease undergoing percutaneous coronary intervention (PCI).
    Phed-on U; Naowapanich S; Poolsawat U; Nimmannit A; Wongpraparut N
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S1-10. PubMed ID: 21728269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.
    Gheorghiade M; Albert NM; Curtis AB; Thomas Heywood J; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Congest Heart Fail; 2012; 18(1):9-17. PubMed ID: 22277172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of using a heart failure management programme in Swedish primary healthcare.
    Agvall B; Alehagen U; Dahlström U
    Eur J Heart Fail; 2013 Feb; 15(2):228-36. PubMed ID: 23109650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.